Services
Market Insights

Insights to understand growth and development opportunities to achieve and retain market share, capture customers and improve the top-line.

Competitive Intelligence

Enhance your organization’s market position and brand perception through strategies that improve value, create differentiation, and address disruption.

Strategic Planning

Navigate today's and tomorrow’s competitive marketplace and enhance your strategic decision-making with concrete insights about the external environment.
Methodologies
Industries

Health + Life Sciences

Financial Services

Energy

Consumer Products + Retail

Diversified Industries
Insights

Whitepapers

Blogs

Case Studies

News + Press

Request a Speaker
Who We Are

Overview

Team

Careers

Competitive Strategy Consulting

By employing a number of sophisticated methodologies that produce a holistic external market view, Fuld + Company helps clients navigate through disruption and create robust and concrete strategies to compete in their dynamic industry environment.

Our expert competitive strategy counsel directly supports strategic planning and executive decision making.

Market Insights

Competitive Intelligence

Strategic Planning

Our practice areas help clients address their specific challenges, bringing clarity to the external environment and identifying competitive strategy advantages and gaps.

Health + Life Science

Financial Services

Energy

Consumer Products + Retail

Diversified Industries

Who We Are

With more than 40 years of experience Fuld+Company has executed more than 10,000 strategic engagements for Global Fortune 1000 firms. Our experts have a comprehensive, critical and objective understanding of the external forces affecting businesses. By tailoring our methodologies to each client’s particular circumstances, we provide specific insights and customized decision support to create robust competitive strategies precisely where and when needed, for the greatest impact.

Learn More Careers

Latest Fuld + Company Perspectives

Faces of Fuld: Q+A with CEO, Diane Borska

Diane Borska, CEO and President, maintains a deep history working with Fuld + Company and has held a variety of […]

Analysis Of The Trastuzumab Biosimilar Market As Herceptin Exclusivity Nears An End

To expand on the Fuld + Company, Pharma Companies to Watch Report, Analyst Robert Browne drilled in on the Biosimilar Marketplace in […]

Evolution In Prostate Cancer Diagnostics Creates New Opportunities For Medtech

In the US, prostate cancer remains a challenge for men’s health, with approximately 174,650 new cases expected in 2019, third […]

View All